CROMSOURCE Acquires Pleiad: Expands US Coverage
CROMSOURCE, an international full service contract research organization (CRO) announced the acquisition of Pleiad, an international CRO with offices in the United States (Cambridge, Mass.) and United Kingdom (Stirling, Scotland).
Pleiad was launched in 1999, supporting clients in multiple therapy areas and with dedicated Medical Device and Ophthalmology Divisions. Additionally,Pleiad also encompasses particularly strong capabilities within statistics and data management.
"We are delighted to welcome Pleiad and its expert team," stated Dr Oriana Zerbini, Chief Executive Officer of CROMSOURCE. "For some time we have wanted to expand and consolidate our presence in the United States and we have now found the perfect way to do so. The opportunity to further add to our UK team and expand our team of experts in data management and statistics is also of great importance to us. With this collaboration CROMSOURCE reinforces its capability to support our clients with even the largest of development programmes in both Europe and the United States."
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
